(S)-(−)-Sulpiride
SIGMA/S7771 - ≥98% (titration)
Synonym: (S)-5-Aminosulfonyl-N-
CAS Number: 23672-07-3
Empirical Formula (Hill Notation): C15H23N3O4S
Molecular Weight: 341.43
MDL Number: MFCD00055220
Linear Formula: C15H23N3O4S
Product Type: Chemical
| assay | ≥98% (titration) |
| InChI | 1S/C15H23N3O4S/c1-3-18-8- |
| InChI key | BGRJTUBHPOOWDU-NSHDSACASA |
| mp | 183-186 °C (lit.) |
| originator | Sanofi Aventis |
| Quality Level | 100  |
| SMILES string | CCN1CCC[C@H]1CNC(=O)c2cc( |
| storage temp. | 2-8°C |
| Application: | (S)-(−)-Sulpiride was used to study the effect of dopamine D2 receptor function on activation of KCNQ potassium channels10 and on depression-like behavior in ovariectomized female rats.11 |
| Biochem/physiol Actions: | (S)-(−)-Sulpiride or Levosulpiride blocks the inhibitory enteric D2 receptors (neuronal and muscular). It has prokinetic activity and is effective in the treatment of functional dyspepsia and gastroparesis in insulin-dependent diabetes mellitus patients.7,8 Since dopamine controls human sexual function, (S)-(−)-Sulpiride is reportedly effective in treatment of erectile dysfunctions.9 |
| Biochem/physiol Actions: | D2 dopamine receptor antagonist; antipsychotic. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 10 g in poly bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (titration) |
| mp | 183-186 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |